Laura Obici

20.3k total citations · 2 hit papers
181 papers, 9.0k citations indexed

About

Laura Obici is a scholar working on Molecular Biology, Nephrology and Cell Biology. According to data from OpenAlex, Laura Obici has authored 181 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Molecular Biology, 31 papers in Nephrology and 26 papers in Cell Biology. Recurrent topics in Laura Obici's work include Amyloidosis: Diagnosis, Treatment, Outcomes (137 papers), Inflammasome and immune disorders (32 papers) and Parathyroid Disorders and Treatments (26 papers). Laura Obici is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (137 papers), Inflammasome and immune disorders (32 papers) and Parathyroid Disorders and Treatments (26 papers). Laura Obici collaborates with scholars based in Italy, United States and United Kingdom. Laura Obici's co-authors include Giampaolo Merlini, Giovanni Palladini, Francesca Lavatelli, Vittorio Perfetti, Stefano Perlini, Teresa Coelho, Remigio Moratti, Claudio Rapezzi, Paola Russo and David Adams and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Laura Obici

175 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guideline of transthyretin-related hereditary amyloidosis for clinicians

2013 493 citations Laura Obici, Claudio Rapezzi et al. profile →
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

2022 218 citations David Adams, Julian D. Gillmore et al. Amyloid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Obici Italy	53	8.1k	1.8k	1.7k	1.3k	1.2k	181	9.0k
Stefan Schönland Germany	43	5.9k 0.7×	1.4k 0.8×	1.5k 0.9×	1.6k 1.2×	632 0.5×	222	7.2k
Bertrand Knebelmann France	46	3.0k 0.4×	1.7k 0.9×	519 0.3×	548 0.4×	1.3k 1.0×	123	6.2k
Jeffrey W. Pippin United States	52	3.5k 0.4×	4.5k 2.5×	715 0.4×	403 0.3×	1.2k 1.0×	130	7.8k
Julie A. Vrana United States	34	2.6k 0.3×	974 0.5×	744 0.4×	343 0.3×	294 0.2×	69	3.6k
Vittorio Perfetti Italy	29	2.6k 0.3×	525 0.3×	744 0.4×	747 0.6×	309 0.2×	80	3.2k
Erinn B. Rankin United States	37	3.4k 0.4×	176 0.1×	1.5k 0.9×	596 0.4×	565 0.5×	71	7.0k
Itaru Matsumura Japan	39	2.5k 0.3×	181 0.1×	1.4k 0.8×	1.2k 0.9×	281 0.2×	216	5.5k
David Plieth United States	13	2.8k 0.4×	1.0k 0.6×	1.4k 0.9×	343 0.3×	380 0.3×	16	5.6k
Jan Voorberg Netherlands	41	1.7k 0.2×	565 0.3×	284 0.2×	1.2k 0.9×	338 0.3×	202	6.6k
John J. Bissler United States	38	2.1k 0.3×	186 0.1×	1.2k 0.7×	358 0.3×	721 0.6×	149	5.6k

Countries citing papers authored by Laura Obici

Since Specialization

Citations

This map shows the geographic impact of Laura Obici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Obici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Obici more than expected).

Fields of papers citing papers by Laura Obici

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Obici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Obici. The network helps show where Laura Obici may publish in the future.

Co-authorship network of co-authors of Laura Obici

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Obici. A scholar is included among the top collaborators of Laura Obici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Obici. Laura Obici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations

Lavatelli, Francesca, Loredana Marchese, P. Patrizia Mangione, et al.. (2025). Role of extracellular space and matrix remodeling in cardiac amyloidosis. Matrix Biology. 140. 100–112. 1 indexed citations

Cappello, Maria, Giovanni Barbara, Massimo Bellini, et al.. (2023). Identification and management of gastrointestinal manifestations of hereditary transthyretin amyloidosis: Recommendations from an Italian group of experts. Digestive and Liver Disease. 56(6). 1014–1020.

Brito, Dulce, Diego Pérez de Arenaza, N. Bart, et al.. (2023). World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). Global Heart. 18(1). 59–59. 33 indexed citations

Luigetti, Marco, Giovanni Antonini, Andrea Di Paolantonio, et al.. (2022). Real‐life experience with inotersen in hereditary transthyretin amyloidosis with late‐onset phenotype: Data from an early‐access program in Italy. European Journal of Neurology. 29(7). 2148–2155. 16 indexed citations

Minnella, Angelo Maria, Elena Antoniazzi, Marco Di Girolamo, et al.. (2021). Ocular Involvement in Hereditary Amyloidosis. Genes. 12(7). 955–955. 42 indexed citations

Obici, Laura & Roberta Mussinelli. (2021). Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter Future. Neurotherapeutics. 18(4). 2286–2302. 13 indexed citations

Maia, Luı́s F., Aleksandra Maleska Maceski, Isabel Conceição, et al.. (2020). Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy. Amyloid. 27(2). 97–102. 43 indexed citations

Gatti, Laura, Francesca Tinelli, Emma Scelzo, et al.. (2020). Understanding the Pathophysiology of Cerebral Amyloid Angiopathy. International Journal of Molecular Sciences. 21(10). 3435–3435. 51 indexed citations

10.

Obici, Laura & David Adams. (2020). Acquired and inherited amyloidosis: Knowledge driving patients' care. Journal of the Peripheral Nervous System. 25(2). 85–101. 12 indexed citations

11.

Obici, Laura & Ole B. Suhr. (2019). Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis. Clinical Autonomic Research. 29(S1). 55–63. 26 indexed citations

12.

Luigetti, Marco, Guido Primiano, Giulia Bisogni, et al.. (2018). Progressive axonal polyneuropathy in a mitochondrial disorder: an uncommon association with familial amyloid neuropathy. Amyloid. 25(4). 261–262. 3 indexed citations

13.

Montagna, G. La, Laura Obici, C. Uggetti, et al.. (2013). Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis. Amyloid. 20(3). 173–178. 21 indexed citations

14.

Nuvolone, Mario, Laura Obici, & Giampaolo Merlini. (2012). Transthyretin-associated Familial Amyloid Polyneuropathy—Current and Emerging Therapies. 8(1). 24–24. 4 indexed citations

15.

Gattorno, Marco, Laura Obici, Jordi Antón, et al.. (2012). Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome. UCL Discovery (University College London). 8 indexed citations

16.

Cappellari, Manuel, Tiziana Cavallaro, Moreno Ferrarini, et al.. (2011). Variable presentations of TTR‐related familial amyloid polyneuropathy in seventeen patients. Journal of the Peripheral Nervous System. 16(2). 119–129. 62 indexed citations

17.

Palladini, Giovanni, Alessandra Barassi, Catherine Klersy, et al.. (2010). The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood. 116(18). 3426–3430. 160 indexed citations

18.

Marchesi, Marta, Cinzia Parolini, Caterina Valetti, et al.. (2010). The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(1). 87–93. 23 indexed citations

19.

Quarta, Candida Cristina, C. Borghi, Stefano Perlini, et al.. (2010). Abstract 16852: A Simple Voltage/Mass Index Improves Diagnosis of Cardiac Amyloidosis in Patients With Unexplained Left Ventricular “Hypertrophy”: An Electrocardiographic and Echocardiographic Study of More Than 500 Patients. Circulation. 122. 4 indexed citations

20.

Salvi, Fabrizio, Cesa Scaglione, Roberto Michelucci, et al.. (2003). Atypical familial motor neuropathy in patients with mutant TTR Ile68Leu. Amyloid. 10(3). 185–189. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact